Aprecap 125 mg Capsules
300 INR/Pack
Product Details:
- Salt Composition Aprepitant 125 mg
- Dosage Form Capsule
- Indication Prevention of nausea and vomiting associated with highly and moderately emetogenic cancer chemotherapy
- Enzyme Types Aprepitant Capsules
- Feature Other
- Ingredients Aprepitant, Excipients
- Application Antiemetic
- Click to View more
X
Aprecap 125 mg Capsules Price And Quantity
- 300 INR/Pack
- 1 Pack
- A04AD12
- 1 blister of 1 capsule or as prescribed
- Oral
- Yes
- Blister strip
- Glenmark Pharmaceuticals Ltd.
Aprecap 125 mg Capsules Product Specifications
- Capsule
- Dry Place
- Odorless
- Antiemetic
- Aprepitant, Excipients
- Aprepitant 125 mg
- 1 Days
- Other
- Aprepitant Capsules
- Light pastel or white colored hard gelatin capsules
- Prevention of nausea and vomiting associated with highly and moderately emetogenic cancer chemotherapy
- A04AD12
- 1 blister of 1 capsule or as prescribed
- Oral
- Yes
- Blister strip
- Glenmark Pharmaceuticals Ltd.
Aprecap 125 mg Capsules Trade Information
- Cash Advance (CA)
- 7 Days
- All India
Product Description
Technical Specification
- Manufactured By : Onkos
- Strength : 125 mg
- Type Of Medicine : Allopathic
- Brand : Aprecap
- Packaging Type : Box
- Packaging Size : 80 Capsules
- Usage/Application : Hospital
Reliable Prevention of Chemotherapy-Induced Nausea
Aprecap 125 mg Capsules offer effective relief from nausea and vomiting associated with cancer therapy, ensuring patient comfort during treatment. This antiemetic solution, containing Aprepitant, is suitable for use with both highly and moderately emetogenic chemotherapy regimens, aiding in better tolerance of cancer therapies.
Easy-to-Use Oral Administration
Conveniently packaged in blister strips, Aprecap 125 mg Capsules are taken orally as prescribed by your healthcare provider. The capsule's hard gelatin form allows for straightforward ingestion, and the single-capsule packaging ensures accurate dosing each time.
Stringent Quality by Glenmark Pharmaceuticals
Aprecap 125 mg is manufactured and marketed by Glenmark Pharmaceuticals Ltd., ensuring high standards for safety, efficacy, and patient care. The product adheres to the ATC code A04AD12 and is widely available for distribution and supply throughout India.
FAQ's of Aprecap 125 mg Capsules:
Q: How should I take Aprecap 125 mg Capsules?
A: Aprecap 125 mg Capsules are to be taken orally as directed by your healthcare provider, typically before chemotherapy sessions to prevent nausea and vomiting. Always follow the prescribed schedule for maximum effectiveness.Q: What is the main benefit of using Aprecap 125 mg Capsules during chemotherapy?
A: The primary benefit of Aprecap 125 mg Capsules is the prevention of nausea and vomiting caused by highly and moderately emetogenic cancer chemotherapy, enhancing patient comfort and adherence to treatment.Q: When should I take the capsule in relation to my chemotherapy treatment?
A: Aprecap 125 mg is generally administered before the start of chemotherapy, as directed by your oncologist, to offer optimal protection against nausea and vomiting during and after treatment.Q: Where should I store Aprecap 125 mg Capsules?
A: Store the capsules in a dry place, away from moisture and heat, to preserve their effectiveness. Ensure that the packaging remains intact until use.Q: What is the process for obtaining Aprecap 125 mg in India?
A: Aprecap 125 mg is a prescription-only medicine, available at pharmacies and distributors across India. You will need a valid prescription from your doctor to purchase the capsules.Q: Who can supply or distribute Aprecap 125 mg in India?
A: Licensed dealers, distributors, exporters, importers, manufacturers, retailers, suppliers, traders, and wholesalers across India are authorized to supply or distribute Aprecap 125 mg Capsules as per regulatory requirements.Tell us about your requirement
Price:
Quantity
Select Unit
- 50
- 100
- 200
- 250
- 500
- 1000+
Additional detail
Mobile number
Email
Other Products in 'Anti Cancer Medicine' category
DEV MEDICAL
All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Private Limited.
Developed and Managed by Infocom Network Private Limited.
